Inovio Pharmaceuticals Inc New/ US45773H4092 /
2024-03-28 9:00:00 PM | Chg. +0.8500 | Volume | Bid10:25:08 PM | Ask10:25:08 PM | High | Low |
---|---|---|---|---|---|---|
13.8800USD | +6.52% | 894,704 Turnover: 10.88 mill. |
13.8000Bid Size: 100 | 14.0000Ask Size: 1,100 | 14.6900 | 13.0000 |
GlobeNewswire
03-28
South Jersey Industries, Inc. Announces Results of Final Remarketing of Series B 1.65% Remarketable ...
GlobeNewswire
03-28
Rackspace Technology Announces Early Tender Results of the Exchange Offer Relating to its 3.50% Firs...
GlobeNewswire
03-28
Epiq Facilitator™ Manages Mass Tort and Class Action Claims in One Secure Platform
GlobeNewswire
03-28
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Loss...
GlobeNewswire
03-28
BLUE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that bluebird bio, Inc. Investors wi...
GlobeNewswire
03-28
SSR Mining (SSRM) Faces Securities Fraud Class Action After Landslide at Turkish Mine – Hagens Berma...
GlobeNewswire
03-28
U.S. Small Business Administration Announces 2024 National Small Business Week Co-Sponsors
GlobeNewswire
03-28
Pixalate’s February 2024 Ad Fraud Research on Global CTV App Spoofing for Roku, Amazon Fire TV, Sams...
GlobeNewswire
03-28
Firsthand Technology Value Fund Announces Fiscal Year Financial Results, NAV of $0.18 Per Share
GlobeNewswire
03-28
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update